Levodopa/benserazide

Levodopa/benserazide, sold under the brand name Prolopa among others, is a fixed-dose combination medication used for the treatment of Parkinson's disease.^[2][3][4]

Levodopa/benserazide

Combination of
Levodopa	Dopamine agonist
Benserazide	Decarboxylase inhibitors
Clinical data
Trade names	Prolopa, Madopar, others[1]
Pregnancy category	AU: B3[2]
Routes of administration	By mouth
ATC code	N04BA02 (WHO)
Legal status
Legal status	AU: S4 (Prescription only)[2] CA: ℞-only[3] UK: POM (Prescription only)[4] In general: ℞ (Prescription only)
Identifiers
KEGG	D02135

Medical uses

Levodopa/benserazide is indicated for the treatment of Parkinson's disease with the exception of drug-induced parkinsonism.^[2][3][4]